Gross Profit On Sales Zmiana Data
ALKERMES USD 319.43M 234.71M 2023-09
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amarin USD 42.5M 14.47M 2023-09
ANI Pharmaceuticals USD 78.23M 5.49M 2023-12
Eisai JPY 140.19B 12.82B 2023-09
Esperion Therapeutics USD 20.59M 1.59M 2023-09
GlaxoSmithKline GBP 5.91B 626M 2023-09
Heron Therapeutics USD 13.23M 1.62M 2023-09
Insmed USD 65.25M 2.88M 2023-12
Ligand Pharmaceuticals USD 26.46M 2.92M 2023-12
Merck USD 11.29B 441M 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Omeros USD 29.67M 1.19M 2021-09
Pacira USD 133.55M 9.38M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Surmodics USD 20.93M 24.63M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Veracyte USD 68.82M 6.32M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Heron Therapeutics Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.